Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
This study is currently recruiting participants.
Verified April 2012 by Massachusetts Eye and Ear Infirmary
Study NCT01072357   Information provided by Massachusetts Eye and Ear Infirmary

First Received on February 18, 2010.   Last Updated on April 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Corneal Neovascularization
Additional conditions recognized in this trial
Neovascularization, Pathologic
More general conditions related to this trial
Corneal Diseases
Eye Diseases
Metaplasia
Pathologic Processes
Interventions listed in this trial
Avastin (bevacizumab)
0.9% NaCl & Refresh Liquigel
Additional drug interventions recognized in this trial
Bevacizumab
Carboxymethylcellulose Sodium
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Gastrointestinal Agents
Growth Inhibitors
Growth Substances
Laxatives
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Massachusetts Eye and Ear Infirmary


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services